Annual Cash & Cash Equivalents
$1.46 M
-$3.86 M-72.57%
September 30, 2024
Summary
- As of February 8, 2025, NMTC annual cash & cash equivalents is $1.46 million, with the most recent change of -$3.86 million (-72.57%) on September 30, 2024.
- During the last 3 years, NMTC annual cash & cash equivalents has fallen by -$5.44 million (-78.84%).
- NMTC annual cash & cash equivalents is now -82.11% below its all-time high of $8.16 million, reached on September 30, 2022.
Performance
NMTC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.46 M
-$160.00 K-9.88%
September 30, 2024
Summary
- As of February 8, 2025, NMTC quarterly cash and cash equivalents is $1.46 million, with the most recent change of -$160.00 thousand (-9.88%) on September 30, 2024.
- Over the past year, NMTC quarterly cash and cash equivalents has dropped by -$3.86 million (-72.57%).
- NMTC quarterly cash and cash equivalents is now -90.98% below its all-time high of $16.18 million, reached on December 31, 2021.
Performance
NMTC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NMTC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.6% | -72.6% |
| 3 y3 years | -78.8% | -91.0% |
| 5 y5 years | +460.0% | -28.6% |
NMTC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.1% | at low | -91.0% | at low |
| 5 y | 5-year | -82.1% | +460.0% | -91.0% | +95.4% |
| alltime | all time | -82.1% | -100.0% | -91.0% | -100.0% |
NeuroOne Medical Technologies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $1.46 M(-72.6%) | $1.46 M(-9.9%) |
| Jun 2024 | - | $1.62 M(-33.5%) |
| Mar 2024 | - | $2.43 M(-9.2%) |
| Dec 2023 | - | $2.68 M(-49.6%) |
| Sep 2023 | $5.32 M(-34.8%) | $5.32 M(+72.6%) |
| Jun 2023 | - | $3.08 M(-14.4%) |
| Mar 2023 | - | $3.60 M(-22.8%) |
| Dec 2022 | - | $4.67 M(-42.8%) |
| Sep 2022 | $8.16 M(+18.2%) | $8.16 M(-19.8%) |
| Jun 2022 | - | $10.18 M(-20.9%) |
| Mar 2022 | - | $12.87 M(-20.5%) |
| Dec 2021 | - | $16.18 M(+134.5%) |
| Sep 2021 | $6.90 M(+71.0%) | $6.90 M(-23.2%) |
| Jun 2021 | - | $8.99 M(-20.3%) |
| Mar 2021 | - | $11.27 M(+58.1%) |
| Dec 2020 | - | $7.13 M(+76.6%) |
| Sep 2020 | $4.04 M(+1448.3%) | $4.04 M(+5.6%) |
| Jun 2020 | - | $3.82 M(+411.8%) |
| Mar 2020 | - | $747.20 K(-63.4%) |
| Dec 2019 | - | $2.04 M(+684.2%) |
| Sep 2019 | $260.70 K(+1860.2%) | $260.70 K(-79.1%) |
| Jun 2019 | - | $1.25 M(-45.9%) |
| Mar 2019 | - | $2.31 M(+557.6%) |
| Dec 2018 | - | $350.60 K(+1451.3%) |
| Sep 2018 | $13.30 K(-49.8%) | - |
| Jun 2018 | - | $22.60 K(-10.3%) |
| Mar 2018 | - | $25.20 K(-4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $26.50 K(-94.9%) | $26.50 K(-62.1%) |
| Sep 2017 | - | $70.00 K(>+9900.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $522.20 K(>+9900.0%) | - |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(-100.0%) |
| Mar 2016 | - | $1800.00(>+9900.0%) |
| Dec 2015 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2015 | - | $200.00(-50.0%) |
| Jun 2015 | - | $400.00(+100.0%) |
| Mar 2015 | - | $200.00(0.0%) |
| Dec 2014 | $200.00(-60.0%) | $200.00(-66.7%) |
| Sep 2014 | - | $600.00(-14.3%) |
| Jun 2014 | - | $700.00(+40.0%) |
| Mar 2014 | - | $500.00(0.0%) |
| Dec 2013 | $500.00(-54.5%) | $500.00(-16.7%) |
| Sep 2013 | - | $600.00(-53.8%) |
| Jun 2013 | - | $1300.00(-74.5%) |
| Mar 2013 | - | $5100.00(+363.6%) |
| Dec 2012 | $1100.00(-92.1%) | $1100.00(-26.7%) |
| Sep 2012 | - | $1500.00(-75.0%) |
| Jun 2012 | - | $6000.00(-27.7%) |
| Mar 2012 | - | $8300.00(-40.3%) |
| Dec 2011 | $13.90 K(+52.7%) | $13.90 K(+183.7%) |
| Sep 2011 | - | $4900.00(+2.1%) |
| Jun 2011 | - | $4800.00(-47.3%) |
| Dec 2010 | $9100.00 | $9100.00 |
FAQ
- What is NeuroOne Medical Technologies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies annual cash & cash equivalents year-on-year change?
- What is NeuroOne Medical Technologies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for NeuroOne Medical Technologies?
- What is NeuroOne Medical Technologies quarterly cash and cash equivalents year-on-year change?
What is NeuroOne Medical Technologies annual cash & cash equivalents?
The current annual cash & cash equivalents of NMTC is $1.46 M
What is the all time high annual cash & cash equivalents for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high annual cash & cash equivalents is $8.16 M
What is NeuroOne Medical Technologies annual cash & cash equivalents year-on-year change?
Over the past year, NMTC annual cash & cash equivalents has changed by -$3.86 M (-72.57%)
What is NeuroOne Medical Technologies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NMTC is $1.46 M
What is the all time high quarterly cash and cash equivalents for NeuroOne Medical Technologies?
NeuroOne Medical Technologies all-time high quarterly cash and cash equivalents is $16.18 M
What is NeuroOne Medical Technologies quarterly cash and cash equivalents year-on-year change?
Over the past year, NMTC quarterly cash and cash equivalents has changed by -$3.86 M (-72.57%)